1Goldman SJ.Preclinical biology of interleukin 11:a multifunctional hematopoietic cytokine with potent thrombopoietic activity.Stem Cells,1995,13(5):462-472.
2Cantor SB,Elting LS,Hudson DV Jr,et al.Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy.Cancer,2003,97:3099-3106.
3Debili N,Wendling F,Katz A,et al.The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative activaties on human megakaryocyte progenitors.Blood,1995,86 (7):2516-2525.
4Peterec SM,Brennan SA,Rinder HM,et al.Reticulated platelet values in normal and thrombocutopenic neonates.J Pediatr,1996,129:269-274.
5Weith NS,Fitzgerald M,Wang A,et al.Recombinant human interleukin-11 synergizes with steel factor and interleukin-3 to promote directly the early stages of murine megakaryocyte development in vitro.J Cell Physiol,1992,153(2):305-312.
